All Collections
Products, Ingredients & Sourcing
The use of liposomal technology in general
The use of liposomal technology in general

liposomal delivery, liposomes, liposomal delivery system, liposomal advanced nutrient-delivery system, liposomal techonology

Margaux avatar
Written by Margaux
Updated over a week ago

We use it in the production of our dietary supplements as a novel approach. Our technology involves encapsulating active ingredients inside liposomes, which are tiny spherical structures composed of a lipid bilayer. This encapsulation method may have several advantages over traditional forms of supplement delivery. One major advantage of this liposomal technology may be improved bioavailability. Liposomes may protect the active ingredients from degradation and may increase their absorption into the bloodstream, leading to potentially higher levels of efficacy. This may likely result in better overall health benefits and faster results, as the active ingredients reach their target tissues in a more efficient manner.

Another advantage of this liposomal technology may be enhanced stability. Liposomes may provide a protective barrier around the active ingredients, which may reduce the risk of oxidation and other chemical reactions that can degrade the potency of the supplement.

This may result in a longer shelf life and more consistent product quality. Liposomal technology may also allow for more precise dosing and greater control over the release of active ingredients. This is because the lipid bilayer of the liposome can be designed to release the active ingredients at a specific rate, ensuring consistent and predictable results. Overall, liposomal technology is a promising advancement in the field of dietary supplements. By helping improve bioavailability, stability, and dosing control, liposomal technology can possibly offer our consumers a more effective and efficient way to supplement their diets and help support their health.

There have been several studies and research conducted on the use of liposomal technology in supplements. Here are a few examples of studies and research on the topic:

  1. "Liposomal Delivery of Vitamin C: Formulation, Characterization, and Clinical Applications," published in Nutrients in 2020, investigated the effectiveness of liposomal vitamin C in enhancing its bioavailability and its potential clinical applications. The study found that liposomal vitamin C had significantly higher bioavailability than traditional vitamin C supplements and may have clinical benefits in areas such as wound healing, immune support, and cancer therapy. Khalili A, Alipour S, Fathalipour M, Purkhosrow A, Mashghoolozekr E, Bayat G, Nekooeian AA. Liposomal and Non-Liposomal Formulations of Vitamin C: Comparison of the Antihypertensive and Vascular Modifying Activity in Renovascular Hypertensive Rats. Iran J Med Sci. 2020 Jan;45(1):41-49. doi: 10.30476/ijms.2019.45310. PMID: 32038058; PMCID: PMC6983272.

  2. "Improved Bioavailability of Curcumin in Liposomal Formulation: Formulation Development and Stability," published in Journal of Food Science in 2019, evaluated the effectiveness of a liposomal curcumin supplement in enhancing its bioavailability. The study found that the liposomal formulation significantly increased the bioavailability of curcumin and had better stability than other formulations.

  3. "Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals," published in Journal of Interferon & Cytokine Research in 2016, investigated the effects of liposomal glutathione supplementation on immune response to Mycobacterium tuberculosis infection in HIV-infected individuals. The study found that the liposomal glutathione supplement significantly improved immune response in these individuals. Ly J, Lagman M, Saing T, Singh MK, Tudela EV, Morris D, Anderson J, Daliva J, Ochoa C, Patel N, Pearce D, Venketaraman V. Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals. J Interferon Cytokine Res. 2015 Nov;35(11):875-87. doi: 10.1089/jir.2014.0210. Epub 2015 Jul 2. PMID: 26133750; PMCID: PMC4642835.

Overall, these studies suggest that liposomal technology can be an effective way to enhance the bioavailability and clinical effectiveness of supplements.

Did this answer your question?